| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.3 | 4e-07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.28 | 2e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |